In Depth | Trulicity: new once-weekly treatment for type II diabetes

Trulicity (dulaglutide) is a once-weekly glucagon-like peptide-1 (GLP-1) agonist for the management of type II diabetes.

by
Trulicity (dulaglutide) is administered at a weekly dose of 750 microgram when used as monotherapy or 1.5mg when used in combination with other antidiabetic agents
Trulicity (dulaglutide) is administered at a weekly dose of 750 microgram when used as monotherapy or 1.5mg when used in combination with other antidiabetic agents

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package